BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• 

  Drug Development

  Four Patients Suffered Serious Adverse Events While on Roche’s Breakthrough Hemophilia Drug

  November 3, 2016

   · 

  2 min read
• BioCapital

  The Rise In Infectious Diseases Is An Opportunity For Biotech Investors

  November 3, 2016

   · 

  1 min read
• BioMidwest

  3 Key Trends In 3D Printing Software

  November 3, 2016

   · 

  1 min read
• With New Owners, Ambrx, Inc. Aims To Challenge Genentech

  November 3, 2016

   · 

  1 min read
• 

  Genetown

  Two Deaths Linked to Bristol-Myers Squibb’s Yervoy-Opdivo Combo

  November 3, 2016

   · 

  3 min read
• 

  Job Trends

  Tiny Novitium Pharma Relocates and Hopes to Hire 150+ New Staffers in the Next Two Years

  November 3, 2016

   · 

  2 min read
• 

  Drug Development

  Gilead Drops Another Bombshell, Will Shift R&D Cash Away From Hep C

  November 3, 2016

   · 

  2 min read
• 

  Drug Development

  Merck & Co.'s Alzheimer’s Contender Wows in Human Clinical Trial

  November 3, 2016

   · 

  3 min read
• Business

  Creative Medical Technology Receives Exclusive License To Key Amniotic Fluid Stem Cell Patent From University Of California System

  November 3, 2016

   · 

  2 min read
• Drug Development

  One Out of the Two Reasons Allergan Paid $640 Million for Vitae Pharma Just Flunked Mid-Stage Test

  November 3, 2016

   · 

  1 min read